|
1
|
Ferrari M, Binzoni T and Quaresima V:
Oxidative metabolism in muscle. Philos Trans R Soc Lond B Biol Sci.
352:677–683. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Atalay M and Hänninen OOP: Muscle energy
metabolism. Atalay M and Hänninen O: Encyclopedia of Life Support
Systems: Physiology and Maintenance. IV. Eolss Publishers Company
Limited; pp. 26–47. 2009
|
|
3
|
Stanley WC, Recchia FA and Lopaschuk GD:
Myocardial substrate metabolism in the normal and failing heart.
Physiol Rev. 85:1093–1129. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hower V, Mendes P, Torti FM, Laubenbacher
R, Akman S, Shulaev V and Torti SV: A general map of iron
metabolism and tissue-specific subnetworks. Mol Biosyst. 5:422–443.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Andrews NC: Disorders of iron metabolism.
N Engl J Med. 341:1986–1995. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Beard JL: Iron biology in immune function,
muscle metabolism and neuronal functioning. J Nutr. 131:568S–579S;
discussion 580S. 2001.PubMed/NCBI
|
|
7
|
Galy B, Ferring-Appel D, Sauer SW, Kaden
S, Lyoumi S, Puy H, Kölker S, Gröne HJ and Hentze MW: Iron
regulatory proteins secure mitochondrial iron sufficiency and
function. Cell Metab. 12:194–201. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ambrose LJ, Abd-Jamil AH, Gomes RS, Carter
EE, Carr CA, Clarke K and Heather LC: Investigating mitochondrial
metabolism in contracting HL-1 cardiomyocytes following hypoxia and
pharmacological HIF activation identifies HIF-dependent and
independent mechanisms of regulation. J Cardiovasc Pharmacol Ther.
19:574–585. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ohlendieck K: Proteomic identification of
biomarkers of skeletal muscle disorders. Biomark Med. 7:169–186.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Finch CA, Miller LR, Inamdar AR, Person R,
Seiler K and Mackler B: Iron deficiency in the rat. Physiological
and biochemical studies of muscle dysfunction. J Clin Invest.
58:447–453. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Davies KJ, Maguire JJ, Brooks GA, Dallman
PR and Packer L: Muscle mitochondrial bioenergetics, oxygen supply,
and work capacity during dietary iron deficiency and repletion. Am
J Physiol. 242:E418–E427. 1982.PubMed/NCBI
|
|
12
|
Henderson SA, Dallman PR and Brooks GA:
Glucose turnover and oxidation are increased in the iron-deficient
anemic rat. Am J Physiol. 250:E414–E421. 1986.PubMed/NCBI
|
|
13
|
Thompson CH, Green YS, Ledingham JG, Radda
GK and Rajagopalan B: The effect of iron deficiency on skeletal
muscle metabolism of the rat. Acta Physiol Scand. 147:85–90. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ponikowska B, Suchocki T, Paleczny B,
Olesinska M, Powierza S, Borodulin-Nadzieja L, Reczuch K, von
Haehling S, Doehner W, Anker SD, et al: Iron status and survival in
diabetic patients with coronary artery disease. Diabetes Care.
36:4147–4156. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Okonko DO, Mandal AK, Missouris CG and
Poole-Wilson PA: Disordered iron homeostasis in chronic heart
failure: Prevalence, predictors, and relation to anemia, exercise
capacity, and survival. J Am Coll Cardiol. 58:1241–1251. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jankowska EA, Rozentryt P, Witkowska A,
Nowak J, Hartmann O, Ponikowska B, Borodulin-Nadzieja L, Banasiak
W, Polonski L, Filippatos G, et al: Iron deficiency: An ominous
sign in patients with systolic chronic heart failure. Eur Heart J.
31:1872–1880. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jankowska EA, Malyszko J, Ardehali H,
Koc-Zorawska E, Banasiak W, von Haehling S, Macdougall IC, Weiss G,
McMurray JJ, Anker SD, et al: Iron status in patients with chronic
heart failure. Eur Heart J. 34:827–834. 2013. View Article : Google Scholar :
|
|
18
|
Bolger AP, Bartlett FR, Penston HS,
O'Leary J, Pollock N, Kaprielian R and Chapman CM: Intravenous iron
alone for the treatment of anemia in patients with chronic heart
failure. J Am Coll Cardiol. 48:1225–1227. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Toblli JE, Lombraña A, Duarte P and Di
Gennaro F: Intravenous iron reduces NT-pro-brain natriuretic
peptide in anemic patients with chronic heart failure and renal
insufficiency. J Am Coll Cardiol. 50:1657–1665. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Anker SD, Comin Colet J, Filippatos G,
Willenheimer R, Dickstein K, Drexler H, Lüscher TF, Bart B,
Banasiak W, Niegowska J, et al: Ferric carboxymaltose in patients
with heart failure and iron deficiency. N Engl J Med.
361:2436–2448. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ponikowski P, van Veldhuisen DJ,
Comin-Colet J, Ertl G, Komajda M, Mareev V, McDonagh T, Parkhomenko
A, Tavazzi L, Levesque V, et al: Beneficial effects of long-term
intravenous iron therapy with ferric carboxymaltose in patients
with symptomatic heart failure and iron deficiency†. Eur Heart J.
36:657–668. 2015. View Article : Google Scholar
|
|
22
|
Okonko DO, Grzeslo A, Witkowski T, Mandal
AK, Slater RM, Roughton M, Foldes G, Thum T, Majda J, Banasiak W,
et al: Effect of intravenous iron sucrose on exercise tolerance in
anemic and nonanemic patients with symptomatic chronic heart
failure and iron deficiency FERRIC-HF: A randomized, controlled,
observer-blinded trial. J Am Coll Cardiol. 51:103–112. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Beck-da-Silva L, Piardi D, Soder S, Rohde
LE, Pereira-Barretto AC, de Albuquerque D, Bocchi E, Vilas-Boas F,
Moura LZ, Montera MW, et al: IRON-HF study: A randomized trial to
assess the effects of iron in heart failure patients with anemia.
Int J Cardiol. 168:3439–3442. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ramey G, Deschemin JC, Durel B,
Canonne-Hergaux F, Nicolas G and Vaulont S: Hepcidin targets
ferroportin for degradation in hepatocytes. Haematologica.
95:501–504. 2010. View Article : Google Scholar :
|
|
25
|
Kuriyama-Matsumura K, Sato H, Yamaguchi M
and Bannai S: Regulation of ferritin synthesis and iron regulatory
protein 1 by oxygen in mouse peritoneal macrophages. Biochem
Biophys Res Commun. 249:241–246. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lok CN and Ponka P: Identification of a
hypoxia response element in the transferrin receptor gene. J Biol
Chem. 274:24147–24152. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cianetti L, Segnalini P, Calzolari A,
Morsilli O, Felicetti F, Ramoni C, Gabbianelli M, Testa U and Sposi
NM: Expression of alternative transcripts of ferroportin-1 during
human erythroid differentiation. Haematologica. 90:1595–1606.
2005.PubMed/NCBI
|
|
28
|
Peyssonnaux C, Nizet V and Johnson RS:
Role of the hypoxia inducible factors HIF in iron metabolism. Cell
Cycle. 7:28–32. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Robach P, Cairo G, Gelfi C, Bernuzzi F,
Pilegaard H, Viganò A, Santambrogio P, Cerretelli P, Calbet JA,
Moutereau S and Lundby C: Strong iron demand during hypoxia-induced
erythropoiesis is associated with down-regulation of iron-related
proteins and myoglobin in human skeletal muscle. Blood.
109:4724–4731. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Woo KJ, Lee TJ, Park JW and Kwon TK:
Desferrioxamine, an iron chelator, enhances HIF-1alpha accumulation
via cyclooxy-genase-2 signaling pathway. Biochem Biophys Res
Commun. 343:8–14. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Parkes JG, Hussain RA, Olivieri NF and
Templeton DM: Effects of iron loading on uptake, speciation, and
chelation of iron in cultured myocardial cells. J Lab Clin Med.
122:36–47. 1993.PubMed/NCBI
|
|
32
|
Hoepken HH1, Korten T, Robinson SR and
Dringen R: Iron accumulation, iron-mediated toxicity and altered
levels of ferritin and transferrin receptor in cultured astrocytes
during incubation with ferric ammonium citrate. J Neurochem.
88:1194–1202. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sakuragi N, Salah-eldin AE, Watari H, Itoh
T, Inoue S, Moriuchi T and Fujimoto S: Bax, Bcl-2, and p53
expression in endometrial cancer. Gynecol Oncol. 86:288–96. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–74. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Aliparasti MR, Alipour MR, Almasi S and
Feizi H: Ghrelin administration increases the Bax/Bcl-2 gene
expression ratio in the heart of chronic hypoxic rats. Adv Pharm
Bull. 5:195–199. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bodine SC and Baehr LM: Skeletal muscle
atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1. Am
J Physiol Endocrinol Metab. 307:E469–E484. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Takenaka M, Noguchi T, Inoue H, Yamada K,
Matsuda T and Tanaka T: Rat pyruvate kinase M gene. Its complete
structure and characterization of the 5′-flanking region. J Biol
Chem. 264:2363–2367. 1989.PubMed/NCBI
|
|
38
|
Jandl JH, Inman JK, Simmons RL and Allen
DW: Transfer of iron from serum iron-binding protein to human
reticulocytes. J Clin Invest. 38:161–185. 1959. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Donovan A, Lima CA, Pinkus JL, Pinkus GS,
Zon LI, Robine S and Andrews NC: The iron exporter
ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab.
1:191–200. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Theil EC: Ferritin: Structure, gene
regulation, and cellular function in animals, plants, and
microorganisms. Annu Rev Biochem. 56:289–315. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ganz T: Hepcidin, a key regulator of iron
metabolism and mediator of anemia of inflammation. Blood.
102:783–788. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Berridge MV, Herst PM and Tan AS:
Tetrazolium dyes as tools in cell biology: New insights into their
cellular reduction. Biotechnol Annu Rev. 11:127–152. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Pfaffl MW: A new mathematical model for
relative quantification in real-time RT-PCR. Nucleic Acids Res.
29:e452001. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Walter PB, Knutson MD, Paler-Martinez A,
Lee S, Xu Y, Viteri FE and Ames BN: Iron deficiency and iron excess
damage mitochondria and mitochondrial DNA in rats. Proc Natl Acad
Sci USA. 99:2264–2269. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ge XH, Wang Q, Qian ZM, Zhu L, Du F, Yung
WH, Yang L and Ke Y: The iron regulatory hormone hepcidin reduces
ferroportin 1 content and iron release in H9C2 cardiomyocytes. J
Nutr Biochem. 20:860–865. 2009. View Article : Google Scholar
|
|
46
|
Parkes JG, Liu Y, Sirna JB and Templeton
DM: Changes in gene expression with iron loading and chelation in
cardiac myocytes and non-myocytic fibroblasts. J Mol Cell Cardiol.
32:233–246. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yoon D, Pastore YD, Divoky V, Liu E,
Mlodnicka AE, Rainey K, Ponka P, Semenza GL, Schumacher A and
Prchal JT: Hypoxia-inducible factor-1 deficiency results in
dysregulated erythropoiesis signaling and iron homeostasis in mouse
development. J Biol Chem. 281:25703–25711. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Rolfs A, Kvietikova I, Gassmann M and
Wenger RH: Oxygen-regulated transferrin expression is mediated by
hypoxia-inducible factor-1. J Biol Chem. 272:20055–20062. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Tacchini L, Bianchi L, Bernelli-Zazzera A
and Cairo G: Transferrin receptor induction by hypoxia.
HIF-1-mediated transcriptional activation and cell-specific
post-transcriptional regulation. J Biol Chem. 274:24142–24146.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Beaumont C: Molecular mechanisms of iron
homeostasis. Med Sci (Paris). 20:68–72. 2004. View Article : Google Scholar
|
|
51
|
Cairo G, Tacchini L, Pogliaghi G, Anzon E,
Tomasi A and Bernelli-Zazzer A: Induction of ferritin synthesis by
oxidative stress. Transcriptional and post-transcriptional
regulation by expansion of the 'free' iron pool. J Biol Chem.
270:700–703. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Chandel NS, McClintock DS, Feliciano CE,
Wood TM, Melendez JA, Rodriguez AM and Schumacker PT: Reactive
oxygen species generated at mitochondrial complex III stabilize
hypoxia-inducible factor-1alpha during hypoxia: A mechanism of O2
sensing. J Biol Chem. 275:25130–25138. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Masso-Silva J, Diamond G, Macias-Rodriguez
M and Ascencio F: Genomic organization and tissue-specific
expression of hepcidin in the pacific mutton hamlet, Alphestes
immaculatus (Breder, 1936). Fish Shellfish Immunol. 31:1297–1302.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Merle U, Fein E, Gehrke SG, Stremmel W and
Kulaksiz H: The iron regulatory peptide hepcidin is expressed in
the heart and regulated by hypoxia and inflammation. Endocrinology.
148:2663–2668. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Przybylowski P, Malyszko J and Malyszko
JS: A possible role of hepcidin in the pathogenesis of anemia in
heart allograft recipients. Transplant Proc. 42:1803–1807. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Smith JJ, O'Brien-Ladner AR, Kaiser CR and
Wesselius LJ: Effects of hypoxia and nitric oxide on ferritin
content of alveolar cells. J Lab Clin Med. 141:309–317. 2003.
View Article : Google Scholar : PubMed/NCBI
|
